SCHEMBL6172830

SCHEMBL6172830

CC(C(=O)O)c1c(C(=O)c2ccc(-c3cccs3)cc2)[nH]c2cc(Cl)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.43
PTGS1 P23219 2/20 0.43
MEN1 O00255 1/20 0.43
ABCC4 O15439 1/20 0.43
C5 P01031 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
PDE4D Q08499 1/20 0.43
GPR17 Q13304 1/20 0.42
CNR1 P21554 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
CYP2C9 P11712 2/20 0.38
LMNA P02545 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
DHODH Q02127 1/20 0.36
TUBB4A P04350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172482 0.87 PTGS2 (0.48) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6171537 0.85 PTGS2 (0.53) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6168997 0.84 PTGS2 (0.52) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6173119 0.83 PTGS2 (0.41) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6172076 0.82 PTGS2 (0.50) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6171863 0.82 PTGS2 (0.50) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6172166 0.81 PTGS2 (0.49) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6172994 0.81 PTGS2 (0.46) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6171661 0.80 PTGS2 (0.43) PTGS2PTGS1MEN1ABCC4C5
SCHEMBL6169445 0.80 GPR17 (0.53) PTGS2GPR17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed